RESUMO
OBJECTIVE: Bleeding of esophageal varices is the main cause of morbidity and mortality in children with portal hypertension. It is important to understand the factors related with a bleeding episode to evaluate more effective primary prophylaxis. The present study aims to describe the endoscopic and laboratory findings associated with upper gastrointestinal bleeding (UGIB) secondary to esophageal varices. METHOD: A cross-sectional study with 103 children and adolescents with cirrhosis, divided into a group that had experienced an episode of upper UGIB (35 patients) and a group without a history of UGIB (68 patients), was carried out. The esophageal and gastric varices were classified, and the portal hypertensive gastropathy, laboratory findings, and Child-Pugh classification were measured. RESULTS: Factors observed in univariate analysis to be associated with UGIB were the presence of esophageal varices of medium caliber or larger, portal hypertensive gastropathy, presence of red spots on esophageal varices, Child-Pugh class B or C, and hypoalbuminemia (Pâ<â0.05). After multivariate logistic regression analysis, the significant factors were the presence of red spots on esophageal varices and the presence of gastric varices. When separated the autoimmune hepatitis, nonbiliary atresia patients (all patients except the patients with biliary atresia), and biliary atresia groups the findings in the univariate analysis were the presence of esophageal varices of medium or larger caliber, presence of red spots on varices, and presence of gastric varices in the autoimmune hepatitis patients and nonbiliary atresia patients and presence of red spots on esophageal varices, presence of gastric varices, and Child-Pugh classification B or C in biliary atresia group (Pâ<â0.05). After multivariate logistic regression analysis, no statistical significance was found for any factor analyzed in any groups. CONCLUSIONS: The presence of gastric varices and red spots on esophageal varices were related to episodes of UGIB secondary to rupture of esophageal varices. When these findings are observed, indications for endoscopic primary prophylaxis should be evaluated. More studies are, however, necessary to better understand this problem.
Assuntos
Varizes Esofágicas e Gástricas/etiologia , Hemorragia Gastrointestinal/etiologia , Cirrose Hepática/complicações , Adolescente , Criança , Pré-Escolar , Estudos Transversais , Varizes Esofágicas e Gástricas/diagnóstico , Feminino , Hemorragia Gastrointestinal/diagnóstico , Humanos , Hipertensão Portal/etiologia , Modelos Logísticos , Masculino , Análise Multivariada , Fatores de RiscoRESUMO
OBJECTIVE: The aim of the present study was to evaluate the treatment adherence of children with chronic functional constipation. METHODS: The present study is a prospective and longitudinal study realized at a pediatric gastroenterology clinic of a Brazilian University Hospital, between August 2009 and October 2011. Rome III criteria and the Bristol Stool Scale were used to define constipation and to characterize feces, respectively. Drug treatment was prescribed for patients according to the protocols previously standardized in the clinic. Specific questionnaires, containing questions related to 1 dependent variable and independent variables were completed in the first and sixth months of the treatment. Independent variables related to the patients, their caregivers, the disease itself, and the therapeutic plan were analyzed and compared with the dependent variable (adherence to the treatment). Adherence was considered when the patient returned with >75% of the prescribed medicine containers empty. RESULTS: Fifty children participated in both the first and sixth months of treatment. The mean age of the sample was 77.6 ± 43.8 months and the mean age of the onset of symptoms was 18.8 ± 27.9 months. The adherence rate was 38% in the first month and 30% in the sixth month. Patients who were treated with polyethylene glycol had greater adherence than patients who were prescribed other laxatives, with statistical significance in the second moment of the study (P = 0.19 and P = 0.04, respectively). CONCLUSIONS: The study showed low adherence rates to drug treatment of constipation in children. It is necessary to seek new strategies to increase treatment adherence, while avoiding complications and reducing costs.
Assuntos
Constipação Intestinal/tratamento farmacológico , Cooperação do Paciente , Adolescente , Instituições de Assistência Ambulatorial , Brasil , Cuidadores , Criança , Pré-Escolar , Doença Crônica , Constipação Intestinal/psicologia , Pai , Fezes , Feminino , Humanos , Renda , Lactente , Laxantes , Estudos Longitudinais , Hidróxido de Magnésio/administração & dosagem , Masculino , Mães , Cooperação do Paciente/psicologia , Polietilenoglicóis/administração & dosagem , Estudos Prospectivos , Psyllium/administração & dosagem , Fatores Socioeconômicos , Inquéritos e QuestionáriosRESUMO
OBJECTIVE: The objective of the present study is to compare daily weight gain and laboratory analysis (72-hour fecal fat and steatocrit) with fecal elastase-1 (EL-1) when diagnosing pancreatic insufficiency (PI) in infants with cystic fibrosis (CF). METHODS: A total of 39 infants with CF, diagnosed consecutively by newborn screening at 2 referral centers, were included in the study. Daily weight gain and results of laboratory analysis of stool samples were compared using the κ coefficient and the receiver operator characteristic (ROC) curve. RESULTS: Using the criterion of low daily weight gain, the frequency of PI was 92.3%; using the 72-hour fecal fat, steatocrit, and fecal EL-1 tests, the frequency was 42.3%, 86.2%, and 84.6%, respectively. EL-1 was used as the reference test. It was observed that the criteria of low daily weight gain (<50th percentile) and abnormal steatocrit, used together, showed the highest sensitivity (91.3%) and specificity (83.3%) for the diagnosis of PI. CONCLUSIONS: When fecal EL-1 analysis is not immediately available, low daily weight gain associated with abnormal steatocrit can be adopted as a criterion for initiating pancreatic enzyme replacement therapy in infants with CF; however, EL-1 testing should be performed later for confirmation of PI.
Assuntos
Fibrose Cística/diagnóstico , Insuficiência Pancreática Exócrina/diagnóstico , Gorduras/metabolismo , Fezes/química , Crescimento , Elastase Pancreática/metabolismo , Aumento de Peso , Fibrose Cística/complicações , Fibrose Cística/metabolismo , Insuficiência Pancreática Exócrina/etiologia , Insuficiência Pancreática Exócrina/metabolismo , Feminino , Transtornos do Crescimento/diagnóstico , Humanos , Lactente , Recém-Nascido , Masculino , Programas de Rastreamento , Curva ROC , Valores de Referência , Sensibilidade e EspecificidadeRESUMO
Intimins of atypical EPEC strains from children with and without diarrhea were genotyped. κ was not found and ß was the most common. η- and ζ-alleles prevailed in strains from children without diarrhea and ι-allele among children older than 13 months. ε-allele emerged in 2006 and was the most common in 2007.
Assuntos
Adesinas Bacterianas/genética , Escherichia coli Enteropatogênica/classificação , Escherichia coli Enteropatogênica/genética , Infecções por Escherichia coli/microbiologia , Proteínas de Escherichia coli/genética , Alelos , Pré-Escolar , Diarreia/microbiologia , Escherichia coli Enteropatogênica/isolamento & purificação , Feminino , Genótipo , Humanos , Lactente , Recém-Nascido , MasculinoRESUMO
OBJETIVO: Avaliar a distribuição e suscetibilidade a antimicrobianos de Shigella isolada de crianças com diarreia aguda e sem diarreia em Teresina (PI). MÉTODOS: Quatrocentas crianças com idade até 60 meses foram estudadas. Fezes foram coletadas de todos os pacientes entre janeiro de 2004 e agosto de 2007. Shigella foi identificada por métodos convencionais e antibiograma e pesquisa de β-lactamase de espectro ampliado (ESBL) foram realizados por difusão em ágar. RESULTADOS: Shigelose foi detectada apenas em crianças com diarreia aguda (26/250; 10,4%), especialmente naquelas entre 6 e 24 meses de idade e nos meses chuvosos. Shigella foi suscetível a ceftriaxona, ciprofloxacina e ácido nalidíxico. Mais da metade das amostras foram resistentes a sulfametoxazol-trimetoprim e ampicilina. ESBL não foi detectada. CONCLUSÕES: S. flexneri é comum em Teresina. A resistência a ampicilina e sulfametoxazol-trimetoprim é preocupante, pois estas drogas são amplamente utilizadas na prática e sulfametoxazol-trimetoprim ainda é recomendada para tratamento de crianças com suspeita de shigelose.
OBJECTIVE: To evaluate the distribution and susceptibility to antimicrobials of Shigella isolated from children with acute diarrhea and without diarrhea in Teresina, state of Piauí, Brazil. METHODS: Four hundred children aged up to 60 months were studied. Stools were collected from all the patients between January 2004 and August 2007. Shigella was identified by conventional methods and antibiogram and extended-spectrum β-lactamase (ESBL) were performed by agar diffusion. RESULTS: Shigellosis was only detected in children with acute diarrhea (26/250; 10.4%), especially in those aged from 6 to 24 months and in the rainy months. Shigella was susceptible to ceftriaxone, ciprofloxacin and nalidixic acid. More than half of the strains were resistant to sulphametoxazole-trimethoprim and ampicillin. ESBL was not detected. CONCLUSIONS: S. flexneri is common in Teresina. The resistance to ampicillin and sulphametoxazole-trimethoprim gives cause for concern, as these drugs are widely used in practice and sulphametoxazole-trimethoprim is also recommended for treating children suspected of having shigellosis.
Assuntos
Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Antibacterianos/farmacologia , Resistência Microbiana a Medicamentos , Diarreia/microbiologia , Fezes/microbiologia , Shigella flexneri/efeitos dos fármacos , Shigella sonnei/efeitos dos fármacos , Doença Aguda , Ampicilina/farmacologia , Brasil , Diarreia/tratamento farmacológico , Métodos Epidemiológicos , Combinação Trimetoprima e Sulfametoxazol/farmacologia , beta-Lactamases/biossínteseRESUMO
OBJECTIVE: To determine the prevalence of hyponatremia at diagnosis in patients with cystic fibrosis and identify the factors associated with changes in serum sodium concentration over time. STUDY DESIGN: This longitudinal study investigated whether variations in serum sodium concentration were associated with age, diet, infection status, and climate/temperature. Multivariate analysis was performed using the random-effects model for longitudinal data. RESULTS: Hyponatremia at diagnosis was observed in 19 of the 20 patients (95%). Factors identified as associated with variations in serum sodium concentration were diet (P = .008) and climate/temperature (P = .005). Intake of solid foods appeared to greatly increase the serum sodium concentration (increase of 5 mEq/L after introduction of solid foods); however, a confounding factor between diet and age cannot be definitively ruled out. Climate/temperature contributed in an inverse way; a 1°C-increase in ambient temperature was associated with a 0.5-mEq/L decrease in serum sodium concentration. CONCLUSION: Infants with cystic fibrosis who feed on breast milk or formula and live in a high-temperature environment are at increased risk for hyponatremia, even when receiving a higher salt intake in accordance with recommendations.
Assuntos
Fibrose Cística/sangue , Hiponatremia/complicações , Sódio/sangue , Aleitamento Materno , Pré-Escolar , Fibrose Cística/diagnóstico , Feminino , Humanos , Hiponatremia/terapia , Lactente , Alimentos Infantis , Fórmulas Infantis , Masculino , Cloreto de Sódio/administração & dosagem , Clima TropicalRESUMO
OBJECTIVE: To evaluate the distribution and susceptibility to antimicrobials of Shigella isolated from children with acute diarrhea and without diarrhea in Teresina, state of Piauí, Brazil. METHODS: Four hundred children aged up to 60 months were studied. Stools were collected from all the patients between January 2004 and August 2007. Shigella was identified by conventional methods and antibiogram and extended-spectrum beta-lactamase (ESBL) were performed by agar diffusion. RESULTS: Shigellosis was only detected in children with acute diarrhea (26/250; 10.4%), especially in those aged from 6 to 24 months and in the rainy months. Shigella was susceptible to ceftriaxone, ciprofloxacin and nalidixic acid. More than half of the strains were resistant to sulphametoxazole-trimethoprim and ampicillin. ESBL was not detected. CONCLUSIONS: S. flexneri is common in Teresina. The resistance to ampicillin and sulphametoxazole-trimethoprim gives cause for concern, as these drugs are widely used in practice and sulphametoxazole-trimethoprim is also recommended for treating children suspected of having shigellosis.
Assuntos
Antibacterianos/farmacologia , Diarreia/microbiologia , Resistência Microbiana a Medicamentos , Fezes/microbiologia , Shigella flexneri/efeitos dos fármacos , Shigella sonnei/efeitos dos fármacos , Doença Aguda , Ampicilina/farmacologia , Brasil , Pré-Escolar , Diarreia/tratamento farmacológico , Métodos Epidemiológicos , Feminino , Humanos , Lactente , Masculino , Combinação Trimetoprima e Sulfametoxazol/farmacologia , beta-Lactamases/biossínteseRESUMO
AIM: To evaluate the treatment of pediatric functional chronic intestinal constipation (FCIC) with a probiotic goat yogurt. METHODS: A crossover double-blind formula-controlled trial was carried out on 59 students (age range: 5-15 years) of a public school in Belo Horizonte, MG, Brazil, presenting a FCIC diagnostic, according to Roma III criteria. The students were randomized in two groups to receive a goat yogurt supplemented with 10(9) colony forming unit/mL Bifidobacterium longum (B. longum) (probiotic) daily or only the yogurt for a period of 5 wk (formula). Afterwards, the groups were intercrossed for another 5 wk. Defecation frequency, stool consistency and abdominal and defecation pain were assessed. RESULTS: Both treatment groups demonstrated improvement in defecation frequency compared to baseline. However, the group treated with probiotic showed most significant improvement in the first phase of the study. An inversion was observed after crossing over, resulting in a reduction in stool frequency when this group was treated by formula. Probiotic and formula improved stool consistency in the first phase of treatment, but the improvement obtained with probiotic was significantly higher (P = 0.03). In the second phase of treatment, the group initially treated with probiotic showed worsening stool consistency when using formula. However, the difference was not significant. A significant improvement in abdominal pain and defecation pain was observed with both probiotic and formula in the first phase of treatment, but again the improvement was more significant for the group treated with B. longum during phase I (P < 0.05). When all data of the crossover study were analyzed, significant differences were observed between probiotic yogurt and yogurt only for defecation frequency (P = 0.012), defecation pain (P = 0.046) and abdominal pain (P = 0.015). CONCLUSION: An improvement in defecation frequency and abdominal pain was observed using both supplemented and non-supplemented yogurt, but an additional improvement with B. longum supplementation was obtained.
Assuntos
Bifidobacterium , Constipação Intestinal/dietoterapia , Probióticos/uso terapêutico , Iogurte/microbiologia , Dor Abdominal/dietoterapia , Dor Abdominal/etiologia , Adolescente , Criança , Pré-Escolar , Constipação Intestinal/complicações , Estudos Cross-Over , Defecação , Método Duplo-Cego , Feminino , Humanos , MasculinoRESUMO
OBJECTIVE: The aim of the study was to determine whether an oral treatment with a commercial pharmaceutical product containing Saccharomyces boulardii would reduce the duration of diarrhea in infants with acute diarrhea. PATIENTS AND METHODS: In the present double-blind, placebo-controlled study, 186 infants, 6 to 48 months old and hospitalized within 72 hours after the onset of acute diarrhea in 2 hospitals in Goiânia, Goiás, Brazil, were randomly assigned to receive twice per day for 5 days 200 mg of a commercial pharmaceutical product containing 4 × 10 viable cells of S boulardii or a placebo. Stool samples were submitted to search for rotavirus. Among the 176 infants who completed the trial, those treated with S boulardii (90) showed a reduction in diarrhea duration (P < 0.05) when compared with the placebo group (86). RESULTS: The present study shows a reduction in diarrhea duration when S boulardii was given to children within 72 hours after the onset of acute diarrhea. CONCLUSIONS: The present study suggests a complementary treatment of acute diarrhea in infants with daily oral doses of S boulardii.
Assuntos
Diarreia/terapia , Probióticos/administração & dosagem , Saccharomyces , Doença Aguda , Administração Oral , Brasil , Pré-Escolar , Método Duplo-Cego , Fezes/química , Fezes/virologia , Feminino , Humanos , Lactente , Masculino , Rotavirus/isolamento & purificaçãoRESUMO
OBJECTIVE: To review the literature on the treatment of gastroesophageal reflux disease (GERD) with emphasis on proton pump inhibitors (PPIs), particularly on delayed-release esomeprazole, and to identify properties and adverse effects of PPIs observed in the treatment of GERD in children and adolescents. SOURCES: Electronic search of PubMed/Medline and Cochrane Collaboration databases, and of abstracts on DDW, NASPGHAN, and ESPGHAN. We focused on controlled and randomized studies published since 2000 and identified reviews that presented a consensual position, and directives published within the last 10 years. MAIN RESULTS: PPIs are considered better antisecretory agents than H(2)-receptor antagonists. Although all PPIs are similar, they are not identical in their pharmacologic properties. For example, the acid-suppressive effect of esomeprazole, the S-isomer of omeprazole, persists for more than 16 hours after administration of the morning dose. Therefore, it can control acidity after night meals better than a single dose of omeprazole. Moreover, the onset of the suppressive effect of esomeprazole is faster. It achieves acid inhibition faster than other PPIs. CONCLUSION: Currently, the mainstream treatment for GERD in children is a PPI. Although PPIs are safe drugs, effective in healing erosive esophagitis, and in relieving symptoms, studies with esomeprazole have shown that this drug has as powerful an ability to inhibit acid secretion as omeprazole. It also seems that some pharmacologic properties of esomeprazole are actually better for the treatment of GERD.
RESUMO
Um amplo espectro de doenças hepáticas crônicas pode se manifestar na faixa etária pediátrica, seja ao nascimento, nos primeiros anos de vida ou mais tardiamente. As hepatopatias crônicas acarretam impacto importante na morbimortalidade, o que enfatiza a necessidade de diagnóstico precoce. Este artigo aborda a conduta diagnóstica inicial frente a uma criança com quadro sugestivo de hepatopatia crônica. (AU)
A wide spectrum of chronic liver disease can manifest in childhood: either at birth, in the first few years of life, or later. Chronic Liver disease mean significant impact on mortality and morbidity, thus early diagnosis is very important. This article discusses the initial diagnostic approach of a child with chronic liver disease. (AU)
Assuntos
Humanos , Recém-Nascido , Lactente , Pré-Escolar , Criança , Saúde da Criança , Cirrose Hepática/diagnóstico , Hepatopatias/diagnóstico , Hepatopatias/complicações , Hepatopatias/diagnóstico por imagem , Hepatopatias/prevenção & controleRESUMO
PURPOSE OF REVIEW: Colonization by the microbiota plays an important role in intestinal tract maturation of newborn. Once installed, indigenous microbiota maintains this modulation and also protects against infectious aggression. Due to these abilities, gut microbiota can be considered a 'microbial organ' that contributes to health of human host. Factors can affect microbiota colonization as well as its maintenance and ingestion of probiotics is a promissory way to counteract these perturbations. This review discusses recent papers dealing with the use of probiotics and their effects on intestinal barrier in children. RECENT FINDINGS: Data obtained from experiments in animal models or cell cultures as well as from clinical trials suggest that probiotics may prevent infectious and inflammatory diseases in which reduction of mucosal barrier functions is involved. SUMMARY: Recent results suggest that probiotics control maturation and maintenance of the intestinal barrier in children. However, human data are limited and more biological and well controlled clinical trials must be carried out for a more precise understanding of the mechanisms underlying the probiotic action and the balance of the complex gastrointestinal ecosystem with which probiotics are expected to interact.
Assuntos
Enteropatias/prevenção & controle , Mucosa Intestinal/microbiologia , Probióticos/uso terapêutico , Animais , Células Cultivadas , Ensaios Clínicos como Assunto , Humanos , Recém-Nascido , Mucosa Intestinal/fisiologia , Modelos AnimaisRESUMO
OBJECTIVES: To define the sensitivity, specificity and accuracy of the ultrasound triangular cord sign and hepatic histopathology, in isolation or in combination, for diagnostic differentiation between biliary atresia and intrahepatic cholestasis. METHODS: This was a retrospective study carried out between January 1990 and December 2004. Fifty-one cases of biliary atresia and 45 of intrahepatic cholestasis were analyzed. Histopathology was performed blind by a pathologist. The triangular cord sign was identified in ultrasound reports as the only diagnostic sign of biliary atresia. Sensitivity, specificity and accuracy were calculated for the triangular cord sign and histology both in isolation and in combination. The gold standard for diagnosis of biliary atresia was the appearance of the extrahepatic biliary tree via laparotomy. RESULTS: The triangular cord sign alone had sensitivity of 49%, specificity of 100% and accuracy of 72.5%. Histopathology compatible with extrahepatic biliary obstruction alone had 90.2% sensitivity, 84.6% specificity and 87.8% accuracy. The triangular cord sign and histopathology in isolation or combination resulted in sensitivity of 93.2%, specificity of 85.7% and accuracy of 90.3%. CONCLUSIONS: Finding the triangular cord sign on ultrasound is an indication for laparotomy. If the triangular cord sign is negative, liver biopsy is indicated; if histopathology reveals signs of biliary atresia, explorative laparotomy is indicated. In cases where the triangular cord sign is absent and histopathology indicates neonatal hepatitis or other intrahepatic cholestasis, clinical treatment or observation are recommended in accordance with the diagnosis.
Assuntos
Atresia Biliar , Colestase Intra-Hepática , Atresia Biliar/diagnóstico por imagem , Atresia Biliar/patologia , Biópsia , Colestase Intra-Hepática/diagnóstico por imagem , Colestase Intra-Hepática/patologia , Diagnóstico Diferencial , Humanos , Lactente , Recém-Nascido , Fígado/patologia , Hepatopatias/diagnóstico , Estudos Retrospectivos , Sensibilidade e Especificidade , UltrassonografiaRESUMO
OBJETIVOS: Definir a sensibilidade, especificidade e a acurácia do espessamento ecogênico periportal à ultra-sonografia e da histopatologia hepática, isolados ou em conjunto, na distinção diagnóstica entre atresia biliar e as colestases intra-hepáticas. MÉTODOS: Trata-se de estudo retrospectivo realizado entre janeiro de 1990 e dezembro de 2004. Foram analisados 51 casos de atresia biliar e 45 com colestase intra-hepática. A histopatologia foi realizada por uma patologista de forma cega. O espessamento ecogênico periportal foi pesquisado na ultra-sonografia como único sinal diagnóstico de atresia biliar. Foram calculados os índices de sensibilidade, especificidade e acurácia do espessamento ecogênico periportal e da histologia isoladamente ou associados. O padrão-ouro utilizado para o diagnóstico de atresia biliar foi o aspecto da via biliar extra-hepática à laparotomia. RESULTADOS: O espessamento ecogênico periportal revelou sensibilidade de 49 por cento, especificidade de 100 por cento e acurácia de 72,5 por cento. A histopatologia compatível com obstrução biliar extra-hepática conferiu sensibilidade de 90,2 por cento, especificidade de 84,6 por cento e acurácia de 87,8 por cento. O espessamento ecogênico periportal e a histopatologia isolados ou associados proporcionaram sensibilidade de 93,2 por cento, especificidade de 85,7 por cento e acurácia de 90,3 por cento. CONCLUSÕES: A evidência do espessamento ecogênico periportal na ultra-sonografia é indicação de laparotomia. Se o espessamento ecogênico periportal é negativo, está indicada a biopsia hepática; se a histopatologia revelar sinais de atresia biliar, impõe-se a laparotomia exploradora. Nos casos de espessamento ecogênico periportal negativo com histopatologia de hepatite neonatal ou de outras colestases intra-hepáticas, recomenda-se o acompanhamento ou o tratamento clínico conforme o diagnóstico.
OBJECTIVES: To define the sensitivity, specificity and accuracy of the ultrasound triangular cord sign and hepatic histopathology, in isolation or in combination, for diagnostic differentiation between biliary atresia and intrahepatic cholestasis. METHODS: This was a retrospective study carried out between January 1990 and December 2004. Fifty-one cases of biliary atresia and 45 of intrahepatic cholestasis were analyzed. Histopathology was performed blind by a pathologist. The triangular cord sign was identified in ultrasound reports as the only diagnostic sign of biliary atresia. Sensitivity, specificity and accuracy were calculated for the triangular cord sign and histology both in isolation and in combination. The gold standard for diagnosis of biliary atresia was the appearance of the extrahepatic biliary tree via laparotomy. RESULTS: The triangular cord sign alone had sensitivity of 49 percent, specificity of 100 percent and accuracy of 72.5 percent. Histopathology compatible with extrahepatic biliary obstruction alone had 90.2 percent sensitivity, 84.6 percent specificity and 87.8 percent accuracy. The triangular cord sign and histopathology in isolation or combination resulted in sensitivity of 93.2 percent, specificity of 85.7 percent and accuracy of 90.3 percent. CONCLUSIONS: Finding the triangular cord sign on ultrasound is an indication for laparotomy. If the triangular cord sign is negative, liver biopsy is indicated; if histopathology reveals signs of biliary atresia, explorative laparotomy is indicated. In cases where the triangular cord sign is absent and histopathology indicates neonatal hepatitis or other intrahepatic cholestasis, clinical treatment or observation are recommended in accordance with the diagnosis.
Assuntos
Humanos , Lactente , Recém-Nascido , Atresia Biliar , Colestase Intra-Hepática , Biópsia , Atresia Biliar/patologia , Atresia Biliar , Colestase Intra-Hepática/patologia , Colestase Intra-Hepática , Diagnóstico Diferencial , Hepatopatias/diagnóstico , Fígado/patologia , Estudos Retrospectivos , Sensibilidade e EspecificidadeRESUMO
OBJECTIVES: This study aims at verifying the prevalence of gastroesophageal reflux in asthmatic children, and at determining the sensitivity and specificity of the reflux index for the diagnosis of gastroesophageal reflux disease. METHODS: Sixty-nine children, aged 1-5 years, with asthma, were studied by 24-hour pH monitoring. The patients were randomly selected. RESULTS: Ages varied from 12.4 to 63.1 months, mean age = 30.79 months, and 62.3% were males. Gastroesophageal reflux was observed in 68.1% of the children. The patients were divided into two groups, moderate and severe asthma, and gastroesophageal reflux was diagnosed in 58.5 and 82.1% of the cases, respectively. Occult gastroesophageal reflux occurred in 31.8% of the cases. The reflux index showed an sensitivity of 89.4%, specificity of 95.5%, positive predictive value of 97.7% and negative predictive value of 80.8%. CONCLUSIONS: The results of this study indicate a relationship between gastroesophageal reflux and asthma, and suggest that the reflux index as a single parameter of pH monitoring has good sensitivity and specificity for the diagnosis of gastroesophageal reflux disease.
Assuntos
Asma/complicações , Refluxo Gastroesofágico/complicações , Pré-Escolar , Estudos Transversais , Feminino , Refluxo Gastroesofágico/diagnóstico , Refluxo Gastroesofágico/epidemiologia , Humanos , Concentração de Íons de Hidrogênio , Lactente , Masculino , Manometria/métodos , Valor Preditivo dos Testes , Prevalência , Sensibilidade e Especificidade , Índice de Gravidade de DoençaRESUMO
OBJETIVOS: Este trabalho tem como objetivo verificar a prevalência do refluxo gastroesofágico em crianças com asma e avaliar se o índice de refluxo tem uma boa sensibilidade e especificidade para o diagnóstico de refluxo gastroesofágico. MÉTODOS: Foram estudadas 69 crianças de 1 a 5 anos, com asma, através do exame de pHmetria de 24 horas. RESULTADOS: A idade das crianças variou de 12,4 a 63,1 meses, com uma média de 30,79, sendo que 62,3 por cento eram do sexo masculino. O refluxo gastroesofágico foi observado em 68,1 por cento das crianças. Quando separados os pacientes em duas categorias (asma moderada e grave), a associação foi de 58,5 e 82,1 por cento, respectivamente. O refluxo gastroesofágico oculto ocorreu em 31,8 por cento dos casos. O índice de refluxo mostrou uma sensibilidade de 89,4 por cento, especificidade de 95,5 por cento, valor preditivo positivo de 97,7 por cento e valor preditivo negativo de 80,8 por cento. CONCLUSÕES: Os resultados obtidos neste estudo indicam uma elevada associação entre o refluxo gastroesofágico e a asma e sugerem que o índice de refluxo, como parâmetro único, tem uma boa sensibilidade e especificidade para o diagnóstico da doença do refluxo gastroesofágico.
OBJECTIVES: This study aims at verifying the prevalence of gastroesophageal reflux in asthmatic children, and at determining the sensitivity and specificity of the reflux index for the diagnosis of gastroesophageal reflux disease. METHODS: Sixty-nine children, aged 1-5 years, with asthma, were studied by 24-hour pH monitoring. The patients were randomly selected. RESULTS: Ages varied from 12.4 to 63.1 months, mean age = 30.79 months, and 62.3 percent were males. Gastroesophageal reflux was observed in 68.1 percent of the children. The patients were divided into two groups, moderate and severe asthma, and gastroesophageal reflux was diagnosed in 58.5 and 82.1 percent of the cases, respectively. Occult gastroesophageal reflux occurred in 31.8 percent of the cases. The reflux index showed an sensitivity of 89.4 percent, specificity of 95.5 percent, positive predictive value of 97.7 percent and negative predictive value of 80.8 percent. CONCLUSIONS: The results of this study indicate a relationship between gastroesophageal reflux and asthma, and suggest that the reflux index as a single parameter of pH monitoring has good sensitivity and specificity for the diagnosis of gastroesophageal reflux disease.
Assuntos
Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Asma/complicações , Refluxo Gastroesofágico/complicações , Estudos Transversais , Refluxo Gastroesofágico/diagnóstico , Refluxo Gastroesofágico/epidemiologia , Concentração de Íons de Hidrogênio , Manometria/métodos , Valor Preditivo dos Testes , Prevalência , Sensibilidade e Especificidade , Índice de Gravidade de DoençaRESUMO
Previous results in the laboratory of the authors showed that Saccharomyces cerevisiae strain 905, isolated during 'cachaça' production, was able to colonize and survive in the gastrointestinal tract of germ-free and conventional mice, and to protect these animals against oral challenge with Salmonella enterica serotype Typhimurium or Clostridium difficile. In the present work, the effects of S. cerevisiae 905 on the translocation of Salm. Typhimurium (mesenteric lymph nodes, Peyer's patches, spleen, liver) as well as on the immune system (number of Küpffer cells, immunoglobulin production, clearance of Escherichia coli B41) were evaluated in gnotobiotic and/or conventional mice. The treatment with the yeast reduced significantly the translocation of Salm. Typhimurium to liver in gnotobiotic animals and to all the organs tested in conventional mice. The number of Küpffer cells per 100 hepatocytes in liver was significantly higher (P<0.05) in yeast mono-associated mice (52.9+/-15.7) than in germ-free controls (38.1+/-9.0). Probably as a consequence, clearance of E. coli B41 from the bloodstream was more efficient in yeast mono-associated animals when compared to germ-free mice. Higher levels (P<0.05) of secretory IgA in intestinal content and of IgA and IgM in serum were observed in yeast mono-associated mice when compared to germ-free group. Concluding, the protection against pathogenic bacteria observed in a previous study was probably due to a modulation of both local and systemic immunity of mice treated with S. cerevisiae 905.
Assuntos
Translocação Bacteriana , Saccharomyces cerevisiae/fisiologia , Salmonelose Animal/imunologia , Salmonelose Animal/microbiologia , Salmonella typhimurium/imunologia , Salmonella typhimurium/patogenicidade , Animais , Anticorpos Antibacterianos/análise , Anticorpos Antibacterianos/sangue , Bacteriemia/imunologia , Modelos Animais de Doenças , Escherichia coli , Infecções por Escherichia coli/imunologia , Fezes/química , Vida Livre de Germes , Imunoglobulina A/sangue , Imunoglobulina A Secretora/análise , Imunoglobulina M/sangue , Células de Kupffer , Fígado/microbiologia , Fígado/patologia , Linfonodos/microbiologia , Camundongos , Nódulos Linfáticos Agregados/microbiologia , Baço/microbiologiaRESUMO
OBJETIVO: Apresentar aspectos relevantes relativos à úlcera péptica gastroduodenal e à infecção pelo Helicobacter pylori na criança e adolescente. FONTES DOS DADOS : Livros técnicos e bases de dados MEDLINE e LILACS de 1966 a 2006. SíNTESE DOS DADOS : A úlcera péptica na criança e adolescente pode ser primária, associada à infecção pelo H. pylori, ou secundária, na qual os mecanismos etiopatogênicos dependem da doença de base. A infecção é adquirida predominantemente na infância, com taxas de prevalência que variam de 56,8 a 83,1 por cento nas crianças que vivem nas regiões mais pobres do Brasil e de aproximadamente 10 por cento nas crianças abaixo de 10 anos de idade nos países desenvolvidos. A infecção pode ser diagnosticada por métodos invasivos, que investigam a presença da bactéria, ou de DNA, RNA ou produtos bacterianos em fragmentos de biópsia da mucosa gástrica obtida à endoscopia; também pode ser diagnosticada através de métodos não-invasivos, que compreendem a pesquisa de anticorpos anti-H. pylori em amostras de soro, urina ou saliva, a pesquisa de antígenos da bactéria nas fezes e o teste respiratório com uréia marcada com carbono-13. O método de escolha para o diagnóstico da úlcera péptica é a endoscopia digestiva alta, com a vantagem adicional de, durante o procedimento, permitir a obtenção de fragmentos de mucosa gástrica para o diagnóstico da infecção e estudo histopatológico. CONCLUSÕES: A infecção por H. pylori é a principal causa de úlcera péptica na infância. A erradicação da bactéria com antimicrobiano é acompanhada de cura da doença, sendo, portanto, indicada em todas as crianças H. pylori-positivas com úlcera péptica em atividade, recorrente, cicatrizada ou complicada.
OBJECTIVE: To show important aspects of gastroduodenal peptic ulcer and of Helicobacter pylori infection in children and adolescents. SOURCES: Technical textbooks and MEDLINE and LILACS databases including publications between 1966 and 2006. SUMMARY OF THE FINDINGS : The etiology of peptic ulcer in children and adolescents may be primary, associated with H. pylori infection, or secondary, in which etiopathogenic mechanisms rely upon the underlying disease. The infection is acquired predominantly in childhood, with prevalence rates between 56.8 and 83.1 percent in children who live in the poorest Brazilian regions, amounting to nearly 10 percent in children aged less than 10 years in industrialized countries. The infection can be diagnosed by invasive methods, which investigate the presence of the bacterium, or of DNA, RNA or bacterial products in biopsy fragments of the gastric mucosa obtained at endoscopic examination; it can also be diagnosed through noninvasive methods, which include the detection of anti-H. pylori antibodies in serum, urine or saliva samples, detection of bacterial antigens in stool samples, and the carbon 13-labeled urea breath test. However, upper gastrointestinal endoscopy is the method of choice for the diagnosis of peptic ulcer, as it allows collecting fragments from the gastric mucosa during the procedure for the diagnosis of infection and for histopathological analysis. CONCLUSIONS: H. pylori infection is the major cause of peptic ulcer among children. Eradication of the bacterium with antimicrobial therapy results in the cure of the disease, and is therefore indicated for all children with H. pylori infection with an active, recurrent, healed, or complicated peptic ulcer.
Assuntos
Adolescente , Criança , Humanos , Úlcera Duodenal/microbiologia , Helicobacter pylori , Infecções por Helicobacter/complicações , Antibacterianos/uso terapêutico , Farmacorresistência Bacteriana/efeitos dos fármacos , Úlcera Duodenal/diagnóstico , Úlcera Duodenal/tratamento farmacológico , Endoscopia Gastrointestinal , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/imunologia , Helicobacter pylori/isolamento & purificação , Helicobacter pylori/patogenicidadeRESUMO
OBJECTIVES: To show important aspects of gastroduodenal peptic ulcer and of Helicobacter pylori infection in children and adolescents. SOURCES: Technical textbooks and MEDLINE and LILACS databases including publications between 1966 and 2006. SUMMARY OF THE FINDINGS: The etiology of peptic ulcer in children and adolescents may be primary, associated with H. pylori infection, or secondary, in which etiopathogenic mechanisms rely upon the underlying disease. The infection is acquired predominantly in childhood, with prevalence rates between 56.8 and 83.1% in children who live in the poorest Brazilian regions, amounting to nearly 10% in children aged less than 10 years in industrialized countries. The infection can be diagnosed by invasive methods, which investigate the presence of the bacterium, or of DNA, RNA or bacterial products in biopsy fragments of the gastric mucosa obtained at endoscopic examination; it can also be diagnosed through noninvasive methods, which include the detection of anti-H. pylori antibodies in serum, urine or saliva samples, detection of bacterial antigens in stool samples, and the carbon 13-labeled urea breath test. However, upper gastrointestinal endoscopy is the method of choice for the diagnosis of peptic ulcer, as it allows collecting fragments from the gastric mucosa during the procedure for the diagnosis of infection and for histopathological analysis. CONCLUSION: H. pylori infection is the major cause of peptic ulcer among children. Eradication of the bacterium with antimicrobial therapy results in the cure of the disease, and is therefore indicated for all children with H. pylori infection with an active, recurrent, healed, or complicated peptic ulcer.
Assuntos
Úlcera Duodenal/microbiologia , Infecções por Helicobacter/complicações , Helicobacter pylori , Adolescente , Antibacterianos/uso terapêutico , Criança , Farmacorresistência Bacteriana/efeitos dos fármacos , Úlcera Duodenal/diagnóstico , Úlcera Duodenal/tratamento farmacológico , Endoscopia Gastrointestinal , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/imunologia , Helicobacter pylori/isolamento & purificação , Helicobacter pylori/patogenicidade , HumanosRESUMO
OBJECTIVE: To review the literature on portal vein thrombosis in children and adolescents, focusing on its diagnosis, complications and treatment. SOURCES OF DATA: The medical literature of the past 10 years was reviewed using the PubMed and MEDLINE search engines, with major focus on portal vein thrombosis and its clinical outcomes. The following keywords or expressions were used for the web search: portal vein thrombosis, extra-hepatic portal vein obstruction, prognosis, children, portal hypertension, esophagogastric varices. Additionally, we also reviewed the articles cited in the references of the initially selected papers, as well as relevant textbooks. SUMMARY OF THE FINDINGS: Portal vein thrombosis is one of the most common causes of portal hypertension among children. The initial clinical manifestation is characterized either by episodes of upper gastrointestinal bleeding or by splenomegaly on routine clinical examination. The major complications include upper gastrointestinal bleeding, hypersplenism secondary to splenomegaly, growth retardation, and portal biliopathy. The diagnosis is made by abdominal Doppler ultrasonography. Treatment is targeted at the complications and includes primary and secondary prophylaxis against upper gastrointestinal bleeding (which results from the rupture of esophageal varices), and portosystemic shunting in selected cases. CONCLUSIONS: Portal vein thrombosis is one of the major triggers of upper gastrointestinal bleeding in children. Bleeding episodes have a remarkable effect on the quality of life of affected patients. Thus, appropriate diagnosis and treatment are needed in order to reduce morbidity and mortality.